Swiss investment company BB Biotech reported an outstanding third quarter in 2025. Here’s why.

War, crises, and capital flows: the global rearmament boom is transforming not only the security landscape but also the ...

Mike Pompeo, former 70th U.S. Secretary of State under the first Trump administration and a self-proclaimed hardliner, set ...

UBS Vice Chairman of the Board of Directors Lukas Gähwiler (60) is unexpectedly stepping down. He will leave UBS in the ...

Swiss entrepreneur reflects on a decade of building Decalia from scratch into one of Geneva’s leading independent asset ...

Swiss Life Asset Managers aims to strengthen its relationships with clients and has created a new division, Marketing & ...

The Family Barometer 2025 by Julius Bär and PwC seeks to highlight current trends among UHNW families when it comes to ...

Blockstream Capital Partners has acquired Zug-based Berglinde, a boutique specializing in Bitcoin-backed lending. The firm ...

Swiss chief financial officers' assessments of the country's business outlook for the next three years have recovered from ...

The former Credit Suisse training center in Horgen changes hands — from major bank UBS to insurance group Swiss Life. The ...

For the first time, the Swiss National Bank (SNB) has published a summary of the discussion held by its Governing Board ...

She wants to turn enthusiasm into impact and enjoys her morning coffee. In this interview, Susanne Kundert, CIO of Globalance ...